TOVX 8-K 2026-08-04

Theriva Biologics, Inc. (TOVX) 8-K dated 2026-08-04 — accession 0001104659-26-090064. This URL is the filing, not the TOVX hub.

Theriva Biologics, Inc. (TOVX) is a biotechnology company listed on NYSE MKT.

Theriva Biologics, Inc. filed a 8-K on 2026-08-04. Accession 0001104659-26-090064.

Cached items: 5.02, 5.07, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.

Not investment advice. The TOVX SEC hub lists recent forms. The stock page is the research view.